Meredith N. Braskie, PhD

The Braskie lab seeks to gain a better understanding of risk factors for Alzheimer’s disease (AD), in particular, vascular and metabolic risk and inflammation. We do this by relating measures of multimodal imaging (structural and functional MRI, diffusion tensor imaging, and amyloid and tau PET) both to relevant blood and cerebrospinal fluid measures and to other medical and demographic data. We collaborate widely, including with wet labs that are researching similar topics.

• Turken Award for Alzheimer’s Disease Research, 2011
• 2009
   -: Ruth L. Kirschstein National Research Service Award, 2009
   – 2010
• 2004
   -: Achievement Rewards for College Scientists (ARCS) fellowship, 2004
   – 2006
• 2003
   -: Ruth L Kirschstein National Research Service Award, 2003
   – 2006
• Bosco S. Tjan Mentorship Award, 2023

• University of California, Los Angeles, Los Angeles, CA — PhD — Neuroscience
• College of William and Mary, Williamsburg, VA — BBA

• Alzheimer's Risk Intervention Trial with Estradiol (ARITE)
  NIH · R01AG102693 · Sep 1, 2026 – Aug 31, 2031 · Role: Co-Principal Investigator
• Effect of diabetes and AD pathology on brain imaging and cognition in Latino adults
  NIH · R01AG078362 · Sep 30, 2022 – Aug 31, 2027 · Role: Co-Principal Investigator
• Neurocognitive Aging & Analytics Research Education (NAARE)
  NIH · R25AG069711 · Jun 1, 2021 – May 31, 2026 · Role: Co-Principal Investigator
• Hippocampal activity and pathology in APOE-4 subjects
  NIH · F31NS045425 · Sep 30, 2003 – Sep 29, 2006 · Role: Principal Investigator

• Thompson, Paul
• Toga, Arthur
• Aisen, Paul
• Zlokovic, Berislav
• Peters, Anne
• Ringman, John